THE FUTURE

OF CANNABIS

For Illustration Purposes Only
Alvit LCS Pharma

ALVIT IS A VERTICALLY INTEGRATED COMPANY WHICH CONTROLS THE ENTIRE LIFE CYCLE OF THE CANNABIS DRUG DEVELOPMENT PROCESS, INCLUDING CONTROLLED CULTIVATION OF PROPRIETARY CANNABIS CLONES UNDER EU-GMP CONDITIONS.

ALVIT LCS PHARMA APPLIES PHARMACEUTICAL METHODOLOGY AND STANDARDISATION TO THE VARIOUS ASPECTS OF CANNABIS

 

Research and Development, Cultivation, Extraction, Processing and Manufacturing.

process-01.png
process-02.png
process-03.png
process-04.png
process-05.png

ALVIT LCS PHARMA DEVELOPS NOVEL CANNABIS-BASED PHARMACEUTICALS

 

At its core, Alvit develops novel cannabis-based pharmaceuticals by combining proprietary formulations and dosage forms with standardized cannabis extracts.

For Illustration Purposes Only

GLOBAL FOOTPRINT

 

Alvit has expanded its global footprint by embarking upon a number of global strategic initiatives in the areas of cultivation, manufacturing and commercialization.